Moira Rynn, MD
- 5Articles
- 18.6KReads1
- 2000–2010Active
- 13Collaborators
- 46Citations2
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Moira Rynn, MD, has contributed to research on anxiety disorders, including generalized anxiety disorder and obsessive-compulsive disorder, focusing on pharmacotherapy approaches. Publications examine treatments such as sertraline, paroxetine, buspirone, and minocycline augmentation. The work spans clinical trials and reviews addressing anxiolytics and depression comorbidities. Rynn's articles appeared between 2000 and 2010 in Psychiatrist.com journals.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
